XOMA Competitors and Similar CompaniesClear all

Humanigen's competitors and similar companies include Moderna.
Humanigen
Humanigen
Humanigen is repositioning and developing its proprietary monoclonal antibodies to meet some critical unmet needs in cancer science.
Moderna
Moderna
Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.
Founding Date
Founding Date
2000
Founding Date
2010
Type
Type
Public
Type
Public
Tags
Locations
Locations
Burlingame, US HQ
Dublin, IE
London, GB
Kansas City, US
Locations
Cambridge, US HQ
Melbourne, AU
Paris, FR
München, DE
Tokyo, JP
Seoul, KR
Warszawa, PL
see more
Employees
Employees
233% decrease
Employees
5,8004% increase
Valuation ($)
Valuation ($)
4.3 m
Valuation ($)
21.2 b

Financial

Revenue (est.)
Revenue (est.)
$2.5m (FY, 2022)
Revenue (est.)
$1.9b (FY, 2025)
Net income
Net income
($70.7m) (FY, 2022)
Net income
($2.8b) (FY, 2025)

Operating

Patent Applications
Patent Applications
17 (FY, 2017)
Patent Applications
430 (FY, 2021)
Patents (Foreign)
Patents (Foreign)
42 (FY, 2017)
Patents (Foreign)
110 (FY, 2021)
Patents (US)
Patents (US)
18 (FY, 2017)
Patents (US)
170 (FY, 2021)

Funding

Total funding raised
Total funding raised
$ 131.7m
Total funding raised
$ 1.8b
For sources of this data, please see the company profile

View Company Profiles

Moderna
HQ
Cambridge, US
Employees
5,800↑ 4% increase

Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.

View company